The goal of this proposed study is to test the hypothesis that replicative life span (RLS) in Candida glabrata enhances azole resistance through regulation of efflux pumps that subsequently leads to drug resistance during infection. Aim 1 is to test whether aging-mediated azole resistance is the result of enhanced transcription for major drug pumps or transport facilitors. Aim 2 is to determine whether the enhanced antiazole activity of the older cells contribute to "clinical" drug resistance. Establishing a correlation between RLS and pathogenicity is a novel concept that the PI has successfully established for the fungal pathogen, Cryptococcus neoformans. In addition, the PI has powerful tools such as the HYAA chip and is poised to …show more content…
albicans. 2. Investigator(s) Strengths • Dr. Fries has considerable training in infectious diseases, pathology, yeast genetics. She is a well-established senior investigator with an extensive publication record. • The PI has previous working experience with RLS in several fungal pathogens including Candida glabrata and has excellent collaborators . Weaknesses • None 3. Innovation Strengths • The HYAA chip assay is a highly innovative technique to assess RLS and morphotype in C. neoformans. • RLS is being examined by the PI in C. neoformans but not in C. glabrata. Study findings that older cells have elevated efflux pumps and are more resistant to antifungals may help to devise new methods of antifungal therapy. Weaknesses • Both HYAA chip assay and RLS vs. drug resistance were previously described by the PI in other organisms. 4. Approach Strengths • Both research aims are well organized and progressive. Each aim contains multiple approaches that help to ensure the likelihood of success. • Preliminary results, though limited, demonstrate that the investigator is fully capable of assessing the role of RLS in drug resistance. • Again, the team has the HYAA-CHIP technology Weaknesses • RLS in C. glabrata may need to
· Be able to describe how antibiotic resistant genes are able to transfer, and identify the transformed cells that are antibiotic resistant
-Multi-drug resistant organisms have increased in number in recent years. Infection control minimizes the onset and spread of these potentially fatal pathogens.
C. elegans was maintained on Escherichia coli OP50 as described.25 C.elegans strains used in this study were wild-type N2, mir-252(n4570), and lys-8 mutant (n?). C. albicans strains used in this study was SC5314 (clinical isolate), a strain that is virulent toward C. elegans, 26. All the used mutants were backcrossed to N2 for at least five times. Double mutant strains without additional marker mutations were constructed using standard genetic methods and verified by complementation testing. At least five independent lines were examined for each rescue experiment. Unless otherwise specified, C. albicans SC5314 was used as the wild-type strain. Yeast strains were grown in liquid yeast extract-peptone-dextrose (YPD)
As the transition to the pseudohyphal growth phase occurs, production of an extracellular matrix begins and continues as the biofilm matures. This matrix is composed primarily of carbohydrates, which differs from the protein-rich matrix of the C. albicans biofilm. As the biofilm grows, non-adherent yeast cells are released from the biofilm and into the surrounding medium to facilitate the spread of infection.(89) Transcription factor Bcr1 is the major regulator of biofilm formation in C. parapsilosis, as in C. albicans, and is required for proper biofilm formation. Bcr1 functions as regulator of several cell wall and adhesion target genes, and at least some targets are conserved in C. parapsilosis.(90,
Aseptic Technique and Culturing Microbes(1) experiment was followed as stated in the lab manual from Clinical Microbiology Class C-453. Aseptic technique was initiated at the beginning of each experiment. Starting by cleansing the work surface with disinfected wipes to prevent cross contamination each time. Utilizing the gloves and personal protective equipment assisted in maintaining a pure culture during the series of experiments. The first step, was to grow the yeast and bacteria cultures. The materials used for the Aseptic Technique Experiment(1) were: test tube rack, 5 mL nutrient broth tubes, pipettes, a lit tea light, Fleischmen’s rapid yeast pack, E. Coli tablet and the S. epidermidis tablet. Started by activating the yeast, by placing the content of Fleischmen’s yeast bag in a disposable cup. Then added approximately 60 mL of warm tap water into the disposable cup. To assist in mixing the two items, I carefully swirled the cup. Once the mixture was combined, it then was left alone for around 10 minutes or until it was frothy. Each nutrient broth tube was labeled with the correct name of the microorganism that was cultured in that tube and dated. The S. epidermidis was selected first, to be cultured. Taking one of the 5mL nutrient broth tube in one hand, the pipette in other hand. The cap was removed with the same hand that had the pipette. Utilizing a lit tea light, like a bunsen burner, I flamed the mouth of the nutrient
Vaginal Candidiasis experience severe vaginal itching, discharge that often looks like cottage cheese. the vagina will appear red, swollen, and painful during sexual contact. Oral Candidiasis will cause white patches on the tongue, inside the cheeks, and on the palette of the mouth. Some effects include immunesupression, mood swings, depression, poor sleep do to discomfort. It also affects the organs like the liver and kidneys. You can develop chronic constipation, canker sores, and gal bladder problems. Vaginal infections can be treated with most over the counter antifungul creams. Including Monistat, Gyne-Lotrimim, and Mycelex. If the case is small then a single dose of oral fluconazole is shown to be effective. When its an oral condition it is usually treated with prescription lozenges or mouthwashes. Other treatments include amphotericin B oral suspension or treatment with systemic azole medications such as Diflucan. Home remedies for vaginal candidiasis include vinegar douches or insertion of a paste made from Lactobacillus acidophilus powder into the
Two recent clinical trials providing new evidence have been published about little-studied agents (i.e., micafungin) with adequate power, which may enhance the reliability and conclusiveness of conclusions14,15. Furthermore, although traditional meta-analyses were completed to estimate the effects with various antifungal agents versus placebo/no intervention, hierarchies among available treatments were uncertain because all of the antifungal agents have not been directly compared13,16,17. Whether there exists an untargeted antifungal agents more effective than others is still ambiguous. Moreover, clinicians administrate antifungal agents prior to definitive diagnosis of IFI should be comprehensively considered. In addition to considering the timing, risk factors and the antifungal agents’ efficacy, affordability is also critical.
Candida is a fungus, which is a form of yeast, and a very small amount of it lives in your mouth and intestines. Its main job? Helping out with digestion and nutrient absorption.
The evolution of resistance is clearly driven by the irrational use of antibiotics which threatens the
(In this study we assume antibiotics aren’t 100% effective and hence don’t kill all bacteria that don’t contain the “novel” enzyme)
1983; Steck et al., 1980), a heterologous strain (Brownlie et al., 1984; Liess et al., 1983), or
Interestingly, the importance of Hsp90 was discovered first through studies in plants and animals. These studies established the involvement of Hsp90 in the conversion from genotype to phenotype (3). Studies of Drosophila determined that Hsp90 acted as a buffer to control the expression of genetic variation and in the case of Hsp90 inhibition, phenotypic effects from new mutaions were masked (3). Using prior knowledge of Hsp90’s role in other eukaryotes as well as original research, the Cowen lab exposed Hsp90’s role in fungal infections and began research into methods to exploit Hsp90’s control for therapeutic techniques. Results from the Cowen lab have numerous applications throughout the medical field. Fungal infections, including systemic
albicans can gain an advantage over the normal bacterial flora. Two common substances are steroids and birth control pills. These both act to alter the host’s body chemistry in a way that is favorable to the over growth of C. albicans. If the host is immunocompromised to begin with as in the case of AIDS patients or organ transplant receivers that are on immunosupresive drugs C. albicans infections are very prominent. A common symptom among AIDS patients is oral thrush, where there is a huge over population of C. albicans on the back of the hosts tongue, it appears as white speckles.
Pre-conditioning with lower doses of ROS can lead to trigger the expression of antioxidant genes to scavenge ROS (Jamieson, 1992), protecting the yeast from cell death due to high levels of ROS inside the cell. This baker’s yeast has proved to be a valuable model system to study human fungal pathogens like Candida albicans, Candida glabrata, etc, in the absence of genetic tools for these organisms. According to evolutionary history, S. cerevisiae and C. albicans got diverged about 300 million years ago (Stajich et al., 2009). Although, they share some common characteristics but are genetically and phenotypically different in many respects and hence makes baker’s yeast a “not so genuine” model for studying fungal pathogens (Karathia et al., 2011; Mohammadi et al., 2015). C. albicans and C. glabrata are the major fungal pathogens responsible for causing life-threatning infections in immunocompromised individuals with mortality rate of more than 50% among fungal infections and rising due to rise in immunocompromised patients (McNeil et al., 2001; Yang et al., 2017; Yapar, 2014). Thus it becomes incumbent upon us to understand the molecular mechanisms of survival of these candida species inside the host, flourish and cause systemic invasive infections. The toolkit of fungal pathogens, C. albicans or C. glabrata to neutralize and survive the damage caused by ROS during respiratory burst inside
For the last three decades, fungal infections have become a major problem worldwide, especially among the immunocompromised individuals (Pfaller MA, Epidemiology of invasive candidiasis, 2007). Despite that Candida is the leading cause of the opportunistic fungal infections, there is a limited number of antimycotics available for therapy (Naglik JR, 2003) (Cannon RD, 2009). Perea et al. (Perea S, 2002) divided antifungal agents commonly used for candidiasis treatment in five major groups basing on their mode of action; group I: inhibition of RNA and/or DNA synthesis (fluorinated pyrimidine analogs 5-FC); group II: alteration of the membrane function (polyenes: nystatin, natamycin, amphotericin B AMB); group III: alteration of cell wall biosynthesis by inhibition of β(1,3)-glucan synthase (echinocandins: caspofungin,